Search

everythinglearnresearchcommunity

for

Search:↓

A bull with a gene mutation was asymptomatic, synthetic retinoids cause hair loss, and new therapeutic targets were identified for skin diseases.

Comprehensive genetic testing and international collaboration are crucial for better understanding and managing Ehlers-Danlos syndromes.

Elastin-like recombinamers show promise for better wound healing and skin regeneration.

Scientists created a cell model to study and find treatments for a skin disease called RDEB.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

Eculizumab helps reduce blood transfusions and stabilize hemoglobin but increases infection risk and is expensive.

EDA is vital for bone and cartilage formation and could help treat skeletal disorders.

Scientists created cell lines to study a genetic skin disorder using CRISPR technology.

A 37-year-old male with severe skin and internal issues has a rare inherited skin condition called dystrophic epidermolysis bullosa.

The document concludes that inherited epidermolysis bullosa is a challenging genetic condition requiring multidisciplinary care and new treatments.

A new mutation in the PLEC gene causes a rare condition with skin blistering, muscle weakness, and hair loss.

Tissue-engineered skin substitutes can model junctional epidermolysis bullosa and may help develop gene therapy.

FERONIA and LRX proteins help control cell growth in plants by regulating vacuole expansion.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

Skin cells from people with Epidermolysis Bullosa Simplex have abnormally placed and less active mitochondria.

A new therapy for a skin blistering condition has not been developed yet.

Recombinant human epidermal growth factor is versatile, effective, and safe for long-term skin and mucosal treatments.

Mouse epidermal growth factor temporarily stops wool growth and causes cell changes in Merino sheep.

The study concluded that specific proteins are necessary to maintain the structure that holds epithelial cells tightly together.

Scientists developed a new way to study mutations in a skin condition using blood cells, which may help diagnose and treat the disease.

Ebastine may promote hair regrowth by increasing cell growth through the ERK pathway.

UBC13 and UBC22 enzymes are important for plant growth and development in Arabidopsis thaliana.

The combination treatment showed a higher response rate but no significant survival benefits.

Early and accurate diagnosis is crucial for managing rare genetic disorders like this localized variant of junctional epidermolysis bullosa.

17β-estradiol can reduce inflammation in the skin.

The model helps test drugs for clubfoot fibrosis by mimicking cell environments and shows minoxidil reduces harmful collagen links.

The study concludes that mutations in the AEBP1 gene can cause a form of Ehlers-Danlos syndrome and should be considered in diagnosis.

DAB labeling effectively identifies collagen type III and PDGFR in horse skin, but may show false positives.

The protein ER71/ETV2 helps regrow hair after chemotherapy by improving the growth of new blood vessels.

ELL is crucial for gene transcription related to skin cell growth.